FRAZIER ALAN D

Director at Alexza Pharmaceuticals Inc. · on record since Mar 14, 2006
Director at RIGEL PHARMACEUTICALS INC · on record since Feb 14, 2006
10% owner at Alexza Pharmaceuticals Inc. · on record since Mar 9, 2006
Director at CADENCE PHARMACEUTICALS INC · on record since Oct 24, 2006
10% owner at CADENCE PHARMACEUTICALS INC · on record since Oct 24, 2006
10% owner at RIGEL PHARMACEUTICALS INC · on record since Feb 23, 2004
10% owner at GLAUKOS Corp · on record since Jun 30, 2015
10% owner at COLLINS INDUSTRIES INC · on record since May 14, 2015
10% owner at ANAPTYSBIO, INC · on record since Jan 31, 2017
10% owner at Sierra Oncology, Inc. · on record since Feb 24, 2017

Insider trading activity of FRAZIER ALAN D

Transactions on record: 76; since Jul 30, 2003

Open-market buys: 0

Open-market sells: 5; $3M

Companies traded: 4; last filing Feb 6, 2017

Figures computed from official regulatory filings — .

Companies where FRAZIER ALAN D has traded

ANAPTYSBIO, INC2 tx · $533.4K · Feb 6, 2017
CADENCE PHARMACEUTICALS INC31 tx · $183.8M · Mar 21, 2014
Alexza Pharmaceuticals Inc.19 tx · May 20, 2010
RIGEL PHARMACEUTICALS INC24 tx · $6M · Aug 8, 2006

Track record of FRAZIER ALAN D

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of FRAZIER ALAN D

Co-insiders of FRAZIER ALAN D

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ANAPTYSBIO, INCListing on record	Feb 6, 2017	OtherD (derivative)	-117,235	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ANAPTYSBIO, INCListing on record	Feb 6, 2017	Other	117,235	4.55 USD	$533.4K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	Other	-3,816,474	14.00 USD	$53.4M	Unusual size	SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-17,500	11.02 USD	$192.9K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-12,500	6.84 USD	$85.5K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-12,500	4.63 USD	$57.9K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-12,500	7.65 USD	$95.6K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-12,500	1.70 USD	$21.3K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	Other	-4,796,711	14.00 USD	$67.2M	Unusual size	SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-25,000	6.79 USD	$169.8K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-10,000	12.64 USD	$126.4K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-12,500	4.75 USD	$59.4K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-15,000	10.80 USD	$162K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 21, 2014	Exercise	1,564,129	7.84 USD	$12.3M		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 21, 2014	ExerciseD (derivative)	-1,564,129	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 21, 2014	ExerciseD (derivative)	-173,792	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 21, 2014	Exercise	173,792	7.84 USD	$1.4M		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 21, 2014	Other	-875,913	14.00 USD	$12.3M	Unusual size	SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 21, 2014	Other	-97,324	14.00 USD	$1.4M	Unusual size	SEC
CADENCE PHARMACEUTICALS INCListing unverified	Jun 13, 2013	AwardD (derivative)	25,000	—	n/a (No price was disclosed in the filing)		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Jun 14, 2012	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Jun 17, 2011	AwardD (derivative)	12,500	—	n/a (No price was disclosed in the filing)		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Jun 17, 2010	AwardD (derivative)	12,500	—	n/a (No price was disclosed in the filing)		SEC
Alexza Pharmaceuticals Inc.Listing unverified	May 20, 2010	AwardD (derivative)	6,250	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Alexza Pharmaceuticals Inc.Listing unverified	Jan 28, 2010	Award	21,008	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
ANAPTYSBIO, INCListing on record	Feb 6, 2017	OtherD (derivative)	-117,235	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
ANAPTYSBIO, INCListing on record	Feb 6, 2017	Other	117,235	4.55 USD	$533.4K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	Other	-3,816,474	14.00 USD	$53.4M	Unusual size	SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-17,500	11.02 USD	$192.9K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-12,500	6.84 USD	$85.5K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-12,500	4.63 USD	$57.9K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-12,500	7.65 USD	$95.6K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-12,500	1.70 USD	$21.3K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	Other	-4,796,711	14.00 USD	$67.2M	Unusual size	SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-25,000	6.79 USD	$169.8K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-10,000	12.64 USD	$126.4K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-12,500	4.75 USD	$59.4K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Mar 21, 2014	OtherD (derivative)	-15,000	10.80 USD	$162K		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 21, 2014	Exercise	1,564,129	7.84 USD	$12.3M		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 21, 2014	ExerciseD (derivative)	-1,564,129	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 21, 2014	ExerciseD (derivative)	-173,792	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 21, 2014	Exercise	173,792	7.84 USD	$1.4M		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 21, 2014	Other	-875,913	14.00 USD	$12.3M	Unusual size	SEC
CADENCE PHARMACEUTICALS INCListing unverified	Feb 21, 2014	Other	-97,324	14.00 USD	$1.4M	Unusual size	SEC
CADENCE PHARMACEUTICALS INCListing unverified	Jun 13, 2013	AwardD (derivative)	25,000	—	n/a (No price was disclosed in the filing)		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Jun 14, 2012	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Jun 17, 2011	AwardD (derivative)	12,500	—	n/a (No price was disclosed in the filing)		SEC
CADENCE PHARMACEUTICALS INCListing unverified	Jun 17, 2010	AwardD (derivative)	12,500	—	n/a (No price was disclosed in the filing)		SEC
Alexza Pharmaceuticals Inc.Listing unverified	May 20, 2010	AwardD (derivative)	6,250	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Alexza Pharmaceuticals Inc.Listing unverified	Jan 28, 2010	Award	21,008	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC